OBJECTIVE： To provide reference of clinical rational use of TCM injections. METHODS： The utilization of TCM injections in our hospital and 23 hospitals of Sichuan province during 2013-2015 were analyzed statistically in terms of species， consumption sum， DDDs， daily drug cost （DDC） and sorting ratio （B/A）， etc. RESULTS： During 2013-2015， the varieties of TCM injections used in our hospital decreased from 36 to 33； the utilization ratio of TCM injections in inpatients was about 60％， while DDDs， consumption sum and constituent ratio increased year by year. In 3 years， Xueshuantong for injection always took up the first place in the list of consumption sum and DDDs in 23 hospitals of Sichuan province； in our hospital， Carthamin yellow for injection took up the first place in the list of consumption sum and DDDs in 2013 and 2014， while Danhong injection and Shenmai injection occupied the first in 2015， respecitively； those were cardio-cere brovascular drugs for promoting blood circulation to remove blood stasis. TCM injections B/A of which were close to 1 in 23 hospitals of Sichuan province were Xueshuantong for injection， Breviscapine for injection and Xiyanping injection， etc. The types of TCM injections B/A of which were close to 1 in our hospital were more than that of Sichuan province. DDC of anti-tumor adjuvant drugs in our hospital were usually higher than those of  cardio-cerebrovascular TCM injection， among which DDC of Xiaoaiping reached 1 328.12 yuan and that of Kanglaite injection was 577.90 yuan； DDDs of those injection were usually in low level. CONCLUSIONS： The application ratio of TCM injections in our hospital was high and showed an upward trend， and sales and use presented a good synchronism. TCM injections with suitable price and definite efficacy take up a large share and the situation is consistent with Sichuan province. Great importance should be attached to ADR risk of TCM injection so as to promote safe， effective and economical ase of drugs.